On March 16, the U.S. Product Safety Commission (CPSC) released an alert informing consumers about a new medication recall. The agency announced that Pfizer Inc., is issuing a recall on its rimegepant medication, which is sold under the brand name Nurtec ODT. This is a "prescription medicine used in adults for the acute treatment of migraine attacks with or without aura [and] the preventive treatment of episodic migraine," according to Pfizer's website.